Caspase-1-deficient or NLRC4-deficient mice show increased colonic epithelial cell proliferation and reduced tumor cell apoptosis resulting in enhanced tumor formation in the colitis-associated colorectal cancer models [141]. Here, CASP1 is linked to colorectal cancer.